Moreover, we observed a decrease in NF+ neurites in both SOD1 mutant MNs, which could be a novel marker for quantification of ALS-related MN degeneration cytopathies in drug screening. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.